scholarly article | Q13442814 |
P356 | DOI | 10.1017/S0033291720001282 |
P698 | PubMed publication ID | 32404212 |
P50 | author | Chantal Michel | Q47268887 |
Frauke Schultze-Lutter | Q47527079 | ||
Jochen Kindler | Q57005652 | ||
Michael Kaess | Q88067324 | ||
Benno G. Schimmelmann | Q114401362 | ||
Martinus Hauf | Q114401363 | ||
Daniela Hubl | Q114401364 | ||
P2860 | cites work | Rethinking schizophrenia | Q22251086 |
Heterogeneity in Incidence Rates of Schizophrenia and Other Psychotic Syndromes | Q22253032 | ||
Revisiting the Basic Symptom Concept: Toward Translating Risk Symptoms for Psychosis into Neurobiological Targets | Q26767499 | ||
Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis | Q26824516 | ||
The precuneus: a review of its functional anatomy and behavioural correlates | Q29615024 | ||
Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition | Q30432820 | ||
Subjective symptoms of schizophrenia in research and the clinic: the basic symptom concept | Q30484431 | ||
Gray matter volumetric abnormalities associated with the onset of psychosis | Q30580970 | ||
Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. | Q33775024 | ||
The orbitofrontal cortex and reward | Q33871858 | ||
Diagnosing schizophrenia in the initial prodromal phase | Q33933362 | ||
Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia | Q33944802 | ||
Accelerated brain aging in schizophrenia and beyond: a neuroanatomical marker of psychiatric disorders | Q34048584 | ||
New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis | Q34196968 | ||
Structure of the psychotic disorders classification in DSM-5. | Q34346688 | ||
EPA guidance on the early detection of clinical high risk states of psychoses | Q34465481 | ||
Regional gray matter volume abnormalities in the at risk mental state | Q34572449 | ||
EPA guidance on the early intervention in clinical high risk states of psychoses. | Q34668473 | ||
Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk | Q34691699 | ||
Static and dynamic characteristics of cerebral blood flow during the resting state in schizophrenia | Q34700962 | ||
Detecting the psychosis prodrome across high-risk populations using neuroanatomical biomarkers | Q35096522 | ||
Progressive Structural Brain Changes During Development of Psychosis | Q35898767 | ||
At risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis prediction | Q36118724 | ||
Psychosis-predictive value of self-reported schizotypy in a clinical high-risk sample | Q36119818 | ||
Insular volume abnormalities associated with different transition probabilities to psychosis | Q36145094 | ||
Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies | Q36386404 | ||
Alterations of lateral temporal cortical gray matter and facial memory as vulnerability indicators for schizophrenia: An MRI study in youth at familial high-risk for schizophrenia | Q36447719 | ||
The role of medial prefrontal cortex in memory and decision making | Q36582780 | ||
Brain Biomarkers of Vulnerability and Progression to Psychosis | Q37124940 | ||
Temporal lobe volume abnormalities precede the prodrome: a study of children presenting antecedents of schizophrenia | Q37228315 | ||
Structural Brain Abnormalities in Youth With Psychosis Spectrum Symptoms | Q37307646 | ||
Middle and inferior temporal gyrus gray matter volume abnormalities in chronic schizophrenia: an MRI study | Q37475507 | ||
The size and burden of mental disorders and other disorders of the brain in Europe 2010. | Q37928182 | ||
Basic symptoms and the prediction of first-episode psychosis | Q37975261 | ||
Cognitive impairment in schizophrenia | Q38048643 | ||
The psychosis high-risk state: a comprehensive state-of-the-art review | Q38061036 | ||
Estimating the true global burden of mental illness | Q38724785 | ||
Ventricular enlargement and progressive reduction of cortical gray matter are linked in prodromal youth who develop psychosis | Q38936884 | ||
Duration of unspecific prodromal and clinical high risk states, and early help-seeking in first-admission psychosis patients | Q38987087 | ||
A stratified model for psychosis prediction in clinical practice | Q39235804 | ||
Different duration of at-risk mental state associated with neurofunctional abnormalities. A multimodal imaging study | Q39289853 | ||
Abnormal involuntary movements are linked to psychosis-risk in children and adolescents: Results of a population-based study | Q40762877 | ||
Social cognition in schizophrenia: an overview | Q43192101 | ||
Interrelated neuropsychological and anatomical evidence of hippocampal pathology in the at-risk mental state | Q46349634 | ||
Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study | Q46816217 | ||
Morphometry of structural disconnectivity indicators in subjects at risk and in age-matched patients with schizophrenia | Q47355545 | ||
Increased Striatal and Reduced Prefrontal Cerebral Blood Flow in Clinical High Risk for Psychosis | Q47357393 | ||
Towards a neurodynamical understanding of the prodrome in schizophrenia | Q47414443 | ||
Course of Cognitive Development From Infancy to Early Adulthood in the Psychosis Spectrum | Q47550049 | ||
Prevalence and clinical relevance of interview-assessed psychosis-risk symptoms in the young adult community. | Q47625645 | ||
Cognitive Subtypes of Schizophrenia Characterized by Differential Brain Volumetric Reductions and Cognitive Decline | Q47883296 | ||
Altered brain function directly related to structural abnormalities in people at ultra high risk of psychosis: longitudinal VBM-fMRI study | Q48152135 | ||
Orbitofrontal morphology in people at high risk of developing schizophrenia | Q48168063 | ||
Neuroanatomical correlates of different vulnerability states for psychosis and their clinical outcomes | Q48470818 | ||
Short-term functional outcome and premorbid adjustment in clinical high-risk patients. Results of the EPOS project. | Q50672781 | ||
Evidence that better outcome of psychosis in women is reversed with increasing age of onset: a population-based 5-year follow-up study. | Q51631434 | ||
Reliability and validity of the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID). | Q51777179 | ||
Reductions in frontal, temporal and parietal volume associated with the onset of psychosis. | Q51886500 | ||
Prediction Models of Functional Outcomes for Individuals in the Clinical High-Risk State for Psychosis or With Recent-Onset Depression | Q56876569 | ||
Psychopathology-a Precision Tool in Need of Re-sharpening | Q57073126 | ||
Inflammatory biomarkers in individuals at clinical high risk for psychosis (CHR-P): State or trait? | Q57166177 | ||
Age effects on basic symptoms in the community: A route to gain new insight into the neurodevelopment of psychosis? | Q58555392 | ||
Improving the clinical prediction of psychosis by combining ultra-high risk criteria and cognitive basic symptoms | Q87419443 | ||
The interrelationship between schizotypy, clinical high risk for psychosis and related symptoms: Cognitive disturbances matter | Q91227850 | ||
P921 | main subject | psychosis | Q170082 |
P304 | page(s) | 1-9 | |
P577 | publication date | 2020-05-14 | |
P1433 | published in | Psychological Medicine | Q7256364 |
P1476 | title | Basic symptoms and gray matter volumes of patients at clinical high risk for psychosis |
Search more.